Related Experiment Video
Updated: Jan 19, 2026

Fast and Accurate Exhaled Breath Ammonia Measurement
Published on: June 11, 2014
Periostin concentration in exhaled breath condensate in children with mild asthma
Patrycja Nejman-Gryz1, Katarzyna Górska1, Katarzyna Krenke2
1Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Warsaw, Poland.
Insights
Exhaled breath condensate (EBC) periostin levels were measured in children with mild asthma. The study found no significant difference in EBC periostin between asthmatic children and controls, suggesting it may not be a useful asthma biomarker.
Area of Science:
- Pulmonary Medicine
- Biomarker Discovery
- Pediatric Asthma Research
Background:
- Periostin is a known marker for eosinophilic inflammation in asthma.
- Limited data exists on periostin levels in exhaled breath condensate (EBC) in pediatric asthma patients.
Purpose of the Study:
- To investigate EBC periostin concentration in children with mild asthma.
- To assess the utility of EBC periostin as a potential biomarker for pediatric asthma.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was used to measure EBC and serum periostin.
- Study included 23 children with asthma and 23 healthy controls.
Main Results:
- EBC periostin concentrations were significantly lower than serum levels (250-780 fold).
- No significant differences in EBC or serum periostin were found between asthmatic children and controls.
- Serum periostin showed an inverse correlation with BMI and age in both groups.
Conclusions:
- Periostin can be measured in both serum and EBC in children with mild asthma.
- Low periostin levels and lack of difference between groups suggest EBC periostin is not a useful asthma biomarker in this pediatric population.
Objective:
Periostin is considered to be a marker of eosinophilic inflammation in patients with asthma. However, there are no literature data on exhaled breath condensate (EBC) periostin level in pediatric patients with asthma. The aim of this study was to analyze EBC periostin concentration in children with mild asthma and to evaluate the potential usefulness of EBC periostin level as a biomarker for the disease.
Methods:
EBC and serum periostin concentrations were measured by enzyme-linked immunosorbent assay in 23 children with asthma and 23 healthy controls.
Results:
EBC periostin concentration was 250- to 780-fold lower than that found in serum. No significant differences between serum nor EBC periostin concentration in asthmatics and the control group were showed. The comparison between children with Th2 and non-Th2 type of asthma did not show significant differences in periostin concentration, both in serum and EBC. Serum periostin concentration inversely correlated with BMI and age not only in asthma patients but also in controls.
Conclusions:
In children with mild asthma, periostin may be measured not only in serum but also in EBC. The low periostin level in patients with mild asthma and lack of difference between asthmatic subjects and controls indicate that EBC periostin may not be useful as an asthma biomarker in this group.
Related Concept Videos
06:27Fast and Accurate Exhaled Breath Ammonia Measurement
06:09Breath Collection from Children for Disease Biomarker Discovery
Breathing
12:08Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells
14:39Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
07:14Acupuncture in a Rat Model of Asthma

